
Individual rapid antigen tests are selling for $100 each with substantially more complaints made about pharmacists than any other kind of retailer, reported The Daily Mail.
The Australian Competition and Consumer Commission has compiled a list of complaints about price gouging for home testing kits.
From Christmas Day to January 7, maximum prices surged from just $14 to $100. This was well above the wholesale costs of $3.95 to $11.45 for one test.
When it came to reported rip offs, pharmacists had the most complaints at 879 during the two-and-a-half week period covering December 25 to January 12.
This was followed by 283 for supermarkets, tobacconists and convenience stores and 272 for petrol stations.
In some cases, retailers are even refusing to give customers a receipt to hide their price gouging.
ACCC chair Rod Sims said retailers selling RATs at a huge mark-up needed to explain themselves.
‘We are asking those businesses to urgently explain the prices they are charging,’ he said.
‘In the middle of a significant outbreak of Covid-19 in a pandemic, the excessive pricing of rapid antigen tests required to diagnose the illness and protect other members of the public, is of significant concern to the ACCC.’
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Elon Musk Leads $97.4 Billion Bid to Take Control of OpenAI
Feb 10, 2025 by
CPI
Nigerian Court Confirms Consumer Protection Commission’s Authority Over Telecom Sector
Feb 10, 2025 by
CPI
Microsoft Under French Antitrust Investigation Over Bing Practices
Feb 10, 2025 by
CPI
Hausfeld Grows Antitrust Litigation Team
Feb 10, 2025 by
CPI
Microsoft Seeks to Ease EU Antitrust Concerns With Office Pricing Adjustment
Feb 10, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – International Criminal Enforcement
Jan 23, 2025 by
CPI
The Antitrust Division’s Recent Work to Combat International Cartels
Jan 23, 2025 by
Emma Burnham & Benjamin Christenson
Information Sharing: The New Frontier of U.S. Antitrust Enforcement
Jan 23, 2025 by
Brian P. Quinn, Casey Kovarik & Michael Tubach
The Key Role of Guidelines on Exchanges of Information Among Competitors and the Divergent Transatlantic Paths
Jan 23, 2025 by
Rosa Abrantes-Metz & Albert Metz
Leniency, Whistleblowers, and Compliance
Jan 23, 2025 by
Richard Powers, Tara O’Malley & Cory Gordon